We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.05B
AUM Growth
-$2.89B
Cap. Flow
-$2.96B
Cap. Flow %
-281.28%
Top 10 Hldgs %
16.51%
Holding
1,419
New
160
Increased
195
Reduced
212
Closed
815

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$19.4M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$19.4M
3
MON
Monsanto Co
MON
+$17.8M
4
ECL icon
Ecolab
ECL
+$17.1M
5
VC icon
Visteon
VC
+$13M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$69.1M
2
GILD icon
Gilead Sciences
GILD
+$59.1M
3
MRK icon
Merck
MRK
+$54.1M
4
WFC icon
Wells Fargo
WFC
+$53.8M
5
X
US Steel
X
+$52.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.13%
2 Technology 13.74%
3 Healthcare 12.34%
4 Financials 12.02%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MASI
276
DELISTED
Masimo
MASI
$993K 0.09%
37,700
GMCR
277
DELISTED
KEURIG GREEN MTN INC
GMCR
$993K 0.09%
7,500
-77,556
-91% -$11M
LDOS icon
278
Leidos
LDOS
$14.1B
$992K 0.09%
+22,800
New +$892K
SNCR
279
DELISTED
Synchronoss Technologies
SNCR
$988K 0.09%
+2,622
New +$1.06M
PBI icon
280
Pitney Bowes
PBI
$2.42B
$987K 0.09%
40,500
+6,900
+21% +$169K
TRP icon
281
TC Energy
TRP
$73.5B
$987K 0.09%
20,100
+4,100
+26% +$199K
BMRN icon
282
BioMarin Pharmaceuticals
BMRN
$11.5B
$985K 0.09%
10,900
-2,900
-21% -$241K
SGI
283
Somnigroup International
SGI
$15.1B
$985K 0.09%
71,776
-104,924
-59% -$1.43M
DNY
284
DELISTED
DONNELLEY R R & SONS CO
DNY
$985K 0.09%
58,600
+5,200
+10% +$87.4K
XL
285
DELISTED
XL Group Ltd.
XL
$984K 0.09%
28,640
-271,094
-90% -$9.24M
OIS icon
286
Oil States International
OIS
$522M
$983K 0.09%
20,100
+5,300
+36% +$286K
RES icon
287
RPC Inc
RES
$1.24B
$983K 0.09%
75,392
+34,200
+83% +$527K
TREX icon
288
Trex
TREX
$4.51B
$983K 0.09%
92,348
-14,400
-13% -$143K
ISBC
289
DELISTED
Investors Bancorp, Inc.
ISBC
$982K 0.09%
87,500
-88,268
-50% -$938K
STJ
290
DELISTED
St Jude Medical
STJ
$982K 0.09%
15,100
+1,200
+9% +$77.3K
CYT
291
DELISTED
CYTEC INDS INC
CYT
$979K 0.09%
21,200
-45,065
-68% -$2.1M
CORE
292
DELISTED
Core Mark Holding Co., Inc.
CORE
$978K 0.09%
31,600
+6,200
+24% +$180K
AIG icon
293
American International
AIG
$41.9B
$976K 0.09%
17,433
-14,000
-45% -$751K
CENX icon
294
Century Aluminum
CENX
$4.57B
$974K 0.09%
39,900
+3,800
+11% +$98.1K
NTAP icon
295
NetApp
NTAP
$32.9B
$974K 0.09%
23,500
-120,109
-84% -$4.99M
QLYS icon
296
Qualys
QLYS
$4.84B
$974K 0.09%
25,800
+4,158
+19% +$139K
MPC icon
297
Marathon Petroleum
MPC
$90.3B
$972K 0.09%
21,540
ODP
298
DELISTED
ODP
ODP
$972K 0.09%
11,340
TROX icon
299
Tronox
TROX
$995M
$972K 0.09%
40,695
+2,048
+5% +$47.4K
ARGO
300
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$971K 0.09%
24,368
+4,870
+25% +$190K

Similar funds

PDT Partners's Q4 2014 Portfolio in Review

As of Q4 2014, PDT Partners held 1,419 positions worth $1.05B, down 73% from $3.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners withdrew a net $2.96B in Q4 2014, closing 815 positions and reducing 212 holdings. Its most notable exit was Gilead Sciences, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PDT Partners opened a new position in Baxter International worth $19.8M.

  • PDT Partners's largest Q4 2014 buy was Baxter International: 498,449 shares worth $19.8M.
  • PDT Partners added most to Visteon in Q4 2014, an estimated $13M increase.
  • PDT Partners's biggest Q4 2014 reduction was Yahoo Inc, cutting an estimated $69.1M.
  • PDT Partners fully exited Gilead Sciences in Q4 2014, selling an estimated $59.1M.
  • PDT Partners's ten largest holdings make up 17% of its $1.05B portfolio in Q4 2014.
  • PDT Partners opened 160 new positions and closed 815 in Q4 2014.
  • PDT Partners's portfolio value fell 73% quarter-over-quarter to $1.05B.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.